Tabula Rasa Healthcare Inc. (TRHC)

47.68
1.63 3.31
NASDAQ : Technology Services
Prev Close 49.31
Open 49.57
Day Low/High 46.62 / 50.37
52 Wk Low/High 40.86 / 91.16
Volume 315.47K
Avg Volume 367.90K
Exchange NASDAQ
Shares Outstanding 21.99M
Market Cap 1.11B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

TRHC: Insiders Vs. Shorts

TRHC: Insiders Vs. Shorts

The most recent short interest data was recently released for the 02/28/2019 settlement date, and Tabula Rasa HealthCare Inc is one of the most shorted stocks of the Russell 3000, based on 7.61 "days to cover" versus the median component at 4.57. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

After The Fall - Will Stocks Spring Back?

After The Fall - Will Stocks Spring Back?

Now that Pennsylvania's Punxsutawney Phil has forecasted an early spring, investment professionals will gather in Philadelphia on February 7 th to hear insights and information about the year ahead for small- and mid-cap stocks at the 2019 Emerald Asset...

TRHC: Insiders Vs. Shorts

TRHC: Insiders Vs. Shorts

The most recent short interest data was recently released for the 11/30/2018 settlement date, and Tabula Rasa HealthCare Inc is one of the most shorted stocks of the Russell 3000, based on 6.49 "days to cover" versus the median component at 5.06. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Interesting TRHC Put And Call Options For November 16th

Interesting TRHC Put And Call Options For November 16th

Investors in Tabula Rasa HealthCare Inc saw new options begin trading this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRHC options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

TRHC Crosses Above Average Analyst Target

TRHC Crosses Above Average Analyst Target

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $57.33, changing hands for $58.24/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week Of August 17th Options Trading For Tabula Rasa HealthCare (TRHC)

First Week Of August 17th Options Trading For Tabula Rasa HealthCare (TRHC)

Investors in Tabula Rasa HealthCare Inc saw new options become available this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRHC options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Tabula Rasa HealthCare Reaches Analyst Target Price

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $51.50, changing hands for $53.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Looking to Add Rayonier and Tabula Rasa as Stocks Seem to Have Bottomed Out

Looking to Add Rayonier and Tabula Rasa as Stocks Seem to Have Bottomed Out

I'm doing selective stock-picking, but not rushing to build up big positions.

CMS Changes To Medicare Part D Provide Potential Expansion Of TRHC Medication Therapy Management Services For Medicare Advantage Plans

CMS Changes To Medicare Part D Provide Potential Expansion Of TRHC Medication Therapy Management Services For Medicare Advantage Plans

Patient Care vs. Administrative Costs Now the Focus of Part D Health Plan Expenditure Ratios

Dr. George Brett Named Senior Vice President Of Consulting For Capstone Performance Systems

Dr. George Brett Named Senior Vice President Of Consulting For Capstone Performance Systems

New Organizational Structure to Improve Efficiency, Accommodate Growth

Facebook's Stock May Start to Infect the Major Indices to a Greater Degree

Facebook's Stock May Start to Infect the Major Indices to a Greater Degree

Selective stock picking continues to be rewarded but the key word here is 'selective'.

Tabula Rasa HealthCare To Exhibit And Present At APhA Annual Meeting And Exposition

Tabula Rasa HealthCare To Exhibit And Present At APhA Annual Meeting And Exposition

Five Poster Presentations. Hugo H. Schaefer Award. Exhibit Booth 140.

THRC's CEO Calvin H. Knowlton, PhD Interviewed On NPR's It's Your Health

THRC's CEO Calvin H. Knowlton, PhD Interviewed On NPR's It's Your Health

Why unintentional misuse of prescription drugs is the 4th leading cause of death in the US

5 Stocks I'm Looking to Buy on Weakness

5 Stocks I'm Looking to Buy on Weakness

This market needs a rest and the action in individual stocks looks weaker.

Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani To Receive American Pharmacists Association's Hugo H. Schaefer Award

Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani To Receive American Pharmacists Association's Hugo H. Schaefer Award

Award recognizes outstanding voluntary contributions to the APhA, the profession and society

TRHC Crosses Above Average Analyst Target

TRHC Crosses Above Average Analyst Target

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $35.71, changing hands for $35.92/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TRHC's Coding School Accepting Applications For New Veterans Scholarship

TRHC's Coding School Accepting Applications For New Veterans Scholarship

Full scholarship will improve access to 12-week immersive program

Tabula Rasa HealthCare CEO Presents At IBC Innovation Day

Tabula Rasa HealthCare CEO Presents At IBC Innovation Day

Calvin H. Knowlton, PhD Focuses on Care Coordination and Readmission Risk

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Here's what you need to know now for Wednesday, Feb. 14.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

While the world's attention turns to Pennsylvania on February 2 nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1 st for the 2018...

Hey Market, Can You Give Me a Minute to Catch My Breath?

Hey Market, Can You Give Me a Minute to Catch My Breath?

If you like buying pullbacks you are out of luck.

TRHC Crosses Above Average Analyst Target

TRHC Crosses Above Average Analyst Target

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $34.00, changing hands for $34.14/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: D+ (Sell)